510(k) K210327
K210327 is an FDA 510(k) premarket notification submitted by W.H.P.M., Inc. for the device "First Sign Multi-Drug Test Dip Card, First Sign Multi-Drug Test Cup, First Sign Multi-Drug Screen Test Dip Card, First Sign Multi-Drug Screen Test Cup". The FDA issued a decision of Substantially Equivalent on Aug 12, 2021. The device falls under product code QBF (Test, Propoxyphene, Over The Counter), a Class II device regulated under 21 CFR 862.3700. W.H.P.M., Inc. has 13 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Aug 12, 2021
- Date Received
- Feb 4, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Test, Propoxyphene, Over The Counter
- Device Class
- Class II
- Regulation Number
- 862.3700
- Review Panel
- TX
- Submission Type
- 510(k)
The propoxyphene test is an in vitro diagnostic test for the qualitative detection of propoxyphene in human urine. The test is intended for over-the-counter use as the first step in a two step process to provide consumers with information concerning the presence or absence of propoxyphene in a urine sample.
Need the full FDA record for W.H.P.M., Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.